Patents by Inventor Hans Michael Haitchi

Hans Michael Haitchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-ADAM33 OLIGONUCLEOTIDES AND RELATED METHODS
    Publication number: 20230095566
    Abstract: The present disclosure provides antisense compounds, methods, and compositions for silencing ADAM33 mRNA. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with ADAM33 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with ADAM33.
    Type: Application
    Filed: June 27, 2022
    Publication date: March 30, 2023
    Inventors: Jonathan Watts, Hans Michael Haitchi, Hannah Pendergraff
  • Anti-ADAM33 oligonucleotides and related methods
    Patent number: 11401519
    Abstract: The present disclosure provides antisense compounds, methods, and compositions for silencing ADAM33 mRNA. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with ADAM33 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with ADAM33.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: August 2, 2022
    Assignees: UNIVERSITY OF MASSACHUSETTS
    Inventors: Jonathan Watts, Hans Michael Haitchi, Hannah Pendergraff
  • ANTI-ADAM33 OLIGONUCLEOTIDES AND RELATED METHODS
    Publication number: 20190002885
    Abstract: The present disclosure provides antisense compounds, methods, and compositions for silencing ADAM33 mRNA. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with ADAM33 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with ADAM33.
    Type: Application
    Filed: June 6, 2018
    Publication date: January 3, 2019
    Inventors: Jonathan Watts, Hans Michael Haitchi, Hannah Pendergraff